P125: Detection of pancreatic cancer in liquid biopsies using integrative fragmentomics
Dolev Rahat +3 more
doaj +1 more source
Liquid Biopsy in Gastrointestinal Cancers: Circulating Tumor DNA for Molecular Residual Disease Assessment and Early Treatment Monitoring. [PDF]
Safiejko K +9 more
europepmc +1 more source
Genomics and Epigenomics Approaches for the Quantification of Circulating Tumor DNA in Liquid Biopsy: Relevance of a Multimodal Strategy. [PDF]
De Paolis E +6 more
europepmc +1 more source
From multi-omics to deep learning: advances in cfDNA-based liquid biopsy for multi-cancer screening. [PDF]
Luo X +13 more
europepmc +1 more source
Dissecting cell-free DNA fragmentation variation in tumors using cell line-derived xenograft mouse. [PDF]
Fu R +5 more
europepmc +1 more source
Circulating tumor DNA-guided early detection and minimal residual disease monitoring in pancreatic and biliary cancers: evidence, barriers, and opportunities. [PDF]
Liu R, Yang Y, Hu Z, Fu Y.
europepmc +1 more source
Early detection of urological tumors based on genomic characteristics of cell-free DNA fragments: a multi-center study. [PDF]
Zhang H +15 more
europepmc +1 more source
Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics. [PDF]
Lapin M +10 more
europepmc +1 more source
Cell-Free DNA Fragmentomics: The Novel Promising Biomarker
Cell-free DNA molecules are released into the plasma via apoptotic or necrotic events and active release mechanisms, which carry the genetic and epigenetic information of its origin tissues. However, cfDNA is the mixture of various cell fragments, and the efficient enrichment of cfDNA fragments with diagnostic value remains a great challenge for ...
Qinyu Ge, Min Pan, Yunfei Bai
exaly +3 more sources

